Market Overview:
The global viral clearance market size reached US$ 725.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,609.0 Million by 2032, exhibiting a growth rate (CAGR) of 19.51% during 2024-2032. The bolstering growth of the biopharmaceutical sector, an increasing number of drug launches, and ongoing technological advancements and innovations represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 725.6 Million |
Market Forecast in 2032
|
US$ 3,609.0 Million |
Market Growth Rate 2024-2032 |
19.51% |
Viral clearance is a process of removing or inactivating viruses from biological products, such as vaccines, biologics, and cell and gene therapies, to ensure their safety for human use. The process involves multiple steps and techniques to effectively eliminate viral contaminants and prevent the transmission of infectious agents. It includes selecting appropriate high-quality starting materials that have a low risk of viral contamination. After this, numerous steps are taken for virus removal and inactivation through filtration, chromatography, and chemical or physical treatments. Finally, the viral clearance process is confirmed through analytical testing, which may include PCR assays, virus culture, and infectivity assays, which ensures that the viral load in the final product is below the acceptable limit and that the product is safe for human use. As a result, viral clearance is extensively used to manufacture biological products.
Viral Clearance Market Trends:
The expanding demand for biopharmaceutical products, such as vaccines, monoclonal antibodies, and recombinant proteins, represents the key factor driving the viral clearance market growth. Besides this, the expanding prevalence of viral infections, such as hepatitis B and C, human immunodeficiency viruses (HIV), and Zika, is impelling the need for effective viral clearance techniques to prevent the transmission of these infections through biopharmaceutical products. Moreover, the introduction of stringent regulations by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is prompting biopharmaceutical manufacturers to implement viral clearance techniques to ensure the safety of their products, which is creating a favorable outlook for the market. In addition to this, the surging demand for specialty drugs and personalized medicine, as well as escalating awareness regarding the benefits of viral clearance products, are presenting remunerative growth opportunities for the market. Furthermore, ongoing innovations in biotechnology, such as gene therapy and cell-based therapies, and numerous technological advancements in viral clearance techniques, including nanofiltration and chromatography, are positively impacting the market growth. Concurrent with this, the increasing number of drug approvals, extensive investments in research and development (R&D) activities, and ongoing mergers and acquisitions between leading players are contributing to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global viral clearance market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on method, application, and end user.
Method Insights:
- Viral Removal
- Chromatography
- Nanofiltration
- Precipitation
- Viral Inactivation
- Low pH
- Solvent Detergent Method
- Heat Pasteurization
- Others
The report has provided a detailed breakup and analysis of the viral clearance market based on the method. This includes viral removal (chromatography, nanofiltration, and precipitation) and viral inactivation (low pH, solvent detergent method, heat pasteurization, and others). According to the report, viral removal represented the largest segment.
Application Insights:
- Recombinant Proteins
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Vaccine
- Others
A detailed breakup and analysis of the viral clearance market based on the applications has also been provided in the report. This includes recombinant proteins, blood and blood products, cellular and gene therapy products, vaccine, and others. According to the report, recombinant proteins accounted for the largest market share.
End User Insights:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Others
The report has provided a detailed breakup and analysis of the viral clearance market based on the end user. This includes pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment.
Regional Insights:
- North America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for viral clearance. Some of the factors driving the North America viral clearance market included the flourishing pharmaceutical and biotechnology industries, ongoing drug launches, and extensive research and development activities.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global viral clearance market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Charles River Laboratories Inc., Creative Biogene Inc, Eurofins Scientific SE, Merck & Co Inc, Sartorius AG, Syngene International Limited (Biocon Ltd), Texcell, WuXi Biologics Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Scope of the Report |
Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: Sensor Type
- Method
- Application
- End User
- Region
|
Methods Covered |
- Viral Removal: Chromatography, Nanofiltration,Precipitation
- Viral Inactivation: Low pH, Solvent Detergent Method, Heat Pasteurization, Others
|
Applications Covered |
Recombinant Proteins, Blood and Blood Products, Cellular and Gene Therapy Products, Vaccine, Others |
End Users Covered |
Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Others |
Regions Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Charles River Laboratories Inc., Creative Biogene Inc, Eurofins Scientific SE, Merck & Co Inc, Sartorius AG, Syngene International Limited (Biocon Ltd), Texcell, WuXi Biologics Inc, etc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global viral clearance market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global viral clearance market?
- What is the impact of each driver, restraint, and opportunity on the global viral clearance market?
- What are the key regional markets?
- Which countries represent the most attractive viral clearance market?
- What is the breakup of the market based on the method?
- Which is the most attractive method in the viral clearance market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the viral clearance market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the viral clearance market?
- What is the competitive structure of the global viral clearance market?
- Who are the key players/companies in the global viral clearance market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the viral clearance market from 2018-2032.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global viral clearance market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the viral clearance industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.